Pediatric Pulmonology

Article	Citations
Clinical characteristics of COVID‐19 in children: A systematic review	195
Clinical manifestations of children with COVID‐19: A systematic review	188
COVID‐19 and multisystem inflammatory syndrome in children: A systematic review and meta‐analysis	117
Pediatric long‐COVID: An overlooked phenomenon?	110
Cystic fibrosis patients of minority race and ethnicity less likely eligible for CFTR modulators based on CFTR genotype	86
During the COVID‐19 pandemic where has respiratory syncytial virus gone?	83
Asthma and COVID‐19 in children: A systematic review and call for data	81
Effect of the COVID‐19 pandemic on anxiety among children with cystic fibrosis and their mothers	69
Impact of COVID‐19 social distancing on viral infection in France: A delayed outbreak of RSV	64
Combining bacteriophages with cefiderocol and meropenem/vaborbactam to treat a pan‐drug resistant Achromobacter species infection in a pediatric cystic fibrosis patient	62
Is vitamin D deficiency a risk factor for COVID‐19 in children?	62
COVID‐19 in childhood: Transmission, clinical presentation, complications and risk factors	59
Influenza and respiratory syncytial virus during the COVID‐19 pandemic: Time for a new paradigm?	54
Efficacy of noninvasive respiratory support modes for primary respiratory support in preterm neonates with respiratory distress syndrome: Systematic review and network meta‐analysis	52
What we know so far about Coronavirus Disease 2019 in children: A meta‐analysis of 551 laboratory‐confirmed cases	47
Efficacy of noninvasive respiratory support modes as postextubation respiratory support in preterm neonates: A systematic review and network meta‐analysis	45
The association between secondhand smoke and childhood asthma: A systematic review and meta‐analysis	42
Effects of the COVID‐19 lockdown on sleep duration in children and adolescents: A survey across different continents	42
Impact of COVID‐19 outbreak in acute bronchiolitis: Lesson from a tertiary Italian Emergency Department	42
Increasing life expectancy in cystic fibrosis: Advances and challenges	42
Neurodevelopmental outcomes of infants with bronchopulmonary dysplasia	41
Pediatric asthma and COVID‐19: The known, the unknown, and the controversial	39
Insight into the pediatric and adult dichotomy of COVID‐19: Age‐related differences in the immune response to SARS‐CoV‐2 infection	38
Unexpected decline in pediatric asthma morbidity during the coronavirus pandemic	38
Psychiatric and general health effects of COVID‐19 pandemic on children with chronic lung disease and parents' coping styles	38

Pediatric lung imaging features of COVID‐19: A systematic review and meta‐analysis	36
Lung growth and pulmonary function after prematurity and bronchopulmonary dysplasia	35
Nusinersen for spinal muscular atrophy type 1: Real‐world respiratory experience	35
Review of CFTR modulators 2020	35
Persistent recovery of pancreatic function in patients with cystic fibrosis after ivacaftor	34
Structural and functional development in airways throughout childhood: Children are not small adults	34
Integration of mental health screening and treatment into cystic fibrosis clinics: Evaluation of initial implementation in 84 programs across the United States	33
Protracted respiratory findings in children post‐SARS‐CoV‐2 infection	33
Pediatric asthma control during the COVID‐19 pandemic: A systematic review and meta‐analysis	32
Care recommendations for the respiratory complications of esophageal atresia‐tracheoesophageal fistula	31
Bacteriophage therapy for infections in CF	31
Overview of gene therapy in spinal muscular atrophy and Duchenne muscular dystrophy	31
Persistent pulmonary hypertension of the newborn	31
Psychological interventions during COVID pandemic: Telehealth for individuals with cystic fibrosis and caregivers	31
Reduction of pulmonary exacerbations in young children with cystic fibrosis during the COVID‐19 pandemic	30
Telemedicine in children with medical complexity on home ventilation during the COVID‐19 pandemic	28
Assessment of respiratory muscles and motor function in children with SMA treated by nusinersen	28
Pediatric P‐ANCA vasculitis following COVID‐19	27
Value of lung ultrasonography to predict weaning success in ventilated neonates	27
Seroprevalence of anti‐SARS‐CoV‐2 IgG antibodies in children with household exposure to adults with COVID‐19: Preliminary findings	27
Reduced pediatric urgent asthma utilization and exacerbations during the COVID‐19 pandemic	27
Oxidant and antioxidant balance in patients with COVID‐19	26
Aerosol transmission of SARS‐CoV‐2 by children and adults during the COVID‐19 pandemic	26
Impact of elexacaftor–tezacaftor–ivacaftor on bacterial colonization and inflammatory responses in cystic fibrosis	25
Pulmonary hypertension in the child with bronchopulmonary dysplasia	25
High flow nasal cannula treatment for obstructive sleep apnea in infants and young children	25
Prevalence of exercise‐induced bronchoconstriction and laryngeal obstruction in adolescent athletes	24
Lung ultrasound in the diagnosis and monitoring of 30 children with coronavirus disease 2019	24
COVID‐19 under 19: A meta‐analysis	24
Risk factors for atopic diseases and recurrent respiratory tract infections in children	23
Practical guide for pediatric pulmonologists on imaging management of pediatric patients with COVID‐19	23
Reproducibility and reference values of diaphragmatic shortening fraction for term and premature infants	23
Effects of the COVID‐19 pandemic and lockdown on symptom control in preschool children with recurrent wheezing	22
Lung ultrasound in bronchiolitis	22
Pulmonary function sequelae after respiratory syncytial virus lower respiratory tract infection in children: A systematic review	22
Technical validity and usability of a novel smartphone‐connected spirometry device for pediatric patients with asthma and cystic fibrosis	22
Exposure to violence, chronic stress, nasal DNA methylation, and atopic asthma in children	21
A narrative review of diaphragmatic ultrasound in pediatric critical care	21
Life with pediatric home ventilation: Expectations versus experience	21
Lung ultrasound for early surfactant treatment: Development and validation of a predictive model	21
Overview: The history and pediatric perspectives of severe acute respiratory syndromes: Novel or just like SARS	21
Immune‐related factors associated with pneumonia in 127 children with coronavirus disease 2019 in Wuhan	20
Bronchopulmonary dysplasia as a determinant of respiratory outcomes in adult life	20
Lung ultrasound predicts histological lung injury in a neonatal model of acute respiratory distress syndrome	20
Rescue of respiratory failure in pulmonary alveolar proteinosis due to pathogenic MARS1 variants	19
Morbidity and respiratory outcomes in infants requiring tracheostomy for severe bronchopulmonary dysplasia	19
Nasal mask vs binasal prongs for nasal continuous positive airway pressure in preterm infants: A systematic review and meta‐analysis	19
Clinical characteristics of acute respiratory syndrome with SARS‐CoV‐2 infection in children in South China	19
Reliability of machine learning to diagnose pediatric obstructive sleep apnea: Systematic review and meta‐analysis	19
Predictors of proper inhaler technique and asthma control in pediatric patients with asthma	19

SARS‐CoV‐2 acute bronchiolitis in hospitalized children: Neither frequent nor more severe	18
Multiple breath washout quality control in the clinical setting	18
Vitamin‐D supplementation as an adjunct to standard treatment of asthma in children: A randomized controlled trial (ViDASTA Trial)	18
Pediatric obstructive sleep apnea—Dental professionals can play a crucial role	18
Ultrasound assessment of diaphragmatic function in type 1 spinal muscular atrophy	18
Ten key points about COVID‐19 in children: The shadows on the wall	18
Obesity‐related asthma in children: A role for vitamin D	18
Efficacy of fiberoptic bronchoscopy and bronchoalveolar lavage in childhood‐onset, complicated plastic bronchitis	18
Real‐time effects of COVID‐19 pandemic lockdown on pediatric respiratory patients	17
Children and COVID‐19: Microbiological and immunological insights	17
Comparison of chest radiography and chest CT for evaluation of pediatric COVID‐19 pneumonia: Does CT add diagnostic value?	17
The effect of the COVID‐19 lockdown on children with asthma‐related symptoms: A tertiary care center experience	17
Delayed acute bronchiolitis in infants hospitalized for COVID‐19	17
Long‐term pulmonary function testing in pediatric bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation	17
The use of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis postliver transplant: A case series	17
Prediction of extubation readiness using lung ultrasound in preterm infants	17
Outcomes of infants born during the first 9 years of CF newborn screening in the United States: A retrospective Cystic Fibrosis Foundation Patient Registry cohort study	16
Frequency of asthma exacerbation in children during the coronavirus disease pandemic with strict mitigative countermeasures	16
Characteristics of infants or children presenting to outpatient bronchopulmonary dysplasia clinics in the United States	16
Diagnostic value of lung ultrasonography in children with COVID‐19	16
Long‐term pulmonary sequelae in adolescents post‐SARS‐CoV‐2 infection	16
Efficacy and safety of EBUS‐TBNA and EUS‐B‐FNA in children: A systematic review and meta‐analysis	16
Can lung ultrasound score accurately predict surfactant replacement? A systematic review and meta‐analysis of diagnostic test studies	16
Respiratory rate is an early predictor of clinical deterioration in children	16
Coronavirus global pandemic: An overview of current findings among pediatric patients	16
Characterizing e‐cigarette vaping‐associated lung injury in the pediatric intensive care unit	16
Azithromycin for preventing bronchopulmonary dysplasia in preterm infants: A systematic review and meta‐analysis	16
The association of area deprivation and state child health with respiratory outcomes of pediatric patients with cystic fibrosis in the United States	16
Decannulation following tracheostomy in children: A systematic review of decannulation protocols	16
Home nursing for children with home mechanical ventilation in the United States: Key informant perspectives	16
Respiratory outcomes of “new” bronchopulmonary dysplasia in adolescents: A multicenter study	16
RSV through the COVID‐19 pandemic: Burden, shifting epidemiology, and implications for the future	15
Detection of disease‐causing CFTR variants in state newborn screening programs	15
Lung ultrasound score and diuretics in preterm infants born before 32 weeks: A pilot study	15
The respiratory impact of novel therapies for spinal muscular atrophy	15
Entering the era of highly effective modulator therapies	15
Restless sleep disorder, restless legs syndrome, and periodic limb movement disorder—Sleep in motion!	15
Clinical characteristics of COVID‐19 in children: Are they similar to those of SARS?	15
Area deprivation and respiratory morbidities in children with bronchopulmonary dysplasia	15
Novel imaging techniques for cystic fibrosis lung disease	15
Secondary household transmission of SARS‐CoV‐2 among children and adolescents: Clinical and epidemiological aspects	15
High flow nasal cannula versus standard low flow nasal oxygen during flexible bronchoscopy in children: A randomized controlled trial	15
Early nasal continuous positive airway pressure failure prediction in preterm infants less than 32 weeks gestational age suffering from respiratory distress syndrome	15
High‐flow nasal cannula vs standard respiratory care in pediatric procedural sedation: A randomized controlled pilot trial	14
Pulmonary pneumatoceles in neonates	14
Diaphragmatic atrophy and dysfunction in critically ill mechanically ventilated children	14
Sleep‐disordered breathing and markers of morbidity in children and adolescents with cystic fibrosis	14
Tracheostomy trends in preterm infants with bronchopulmonary dysplasia in the United States: 2008–2017	14
CFTR modulator drug desensitization: Preserving the hope of long term improvement	14
Elexacaftor–Tezacaftor–Ivacaftor improves exercise capacity in adolescents with cystic fibrosis	14
Chylothorax in the neonate—A stepwise approach algorithm	14
The importance of anti‐vaping vigilance—EVALI in seven adolescent pediatric patients in Northeast Ohio	14
Physical activity in children and adolescents with cystic fibrosis: A systematic review and meta‐analysis	14
Outcomes of early repeat sweat testing in infants with cystic fibrosis transmembrane conductance regulator‐related metabolic syndrome/CF screen‐positive, inconclusive diagnosis	13
Pierre Robin and breathing: What to do and when?	13
Tracheal anomalies associated with Down syndrome: A systematic review	13
Bronchoscopy in children with COVID‐19: A case series	13
Agreement between spirometry and impulse oscillometry for lung function assessment in 6‐year‐old children born extremely preterm and at term	13
Nutrition and growth in infants with established bronchopulmonary dysplasia	13
Lung clearance index: A new measure of late lung complications of cancer therapy in children	13
Digital auscultation in PERCH: Associations with chest radiography and pneumonia mortality in children	13
Liberation and mortality outcomes in pediatric long‐term ventilation: A qualitative systematic review	13
Oscillometry—A reasonable option to monitor lung functions in the era of COVID‐19 pandemic	13
Healthcare utilization and costs of pediatric home mechanical ventilation in Canada	13
Laboratory parameters between multisystem inflammatory syndrome in children and Kawasaki disease	13
Depression and anxiety in mothers of home ventilated children before and during COVID‐19 pandemic	13
SARS‐CoV‐2 and Streptococcus pneumoniae coinfection as a cause of severe pneumonia in an infant	13
Impact of nonpharmacological COVID‐19 interventions in hospitalizations for childhood pneumonia in Brazil	13
Sustained recovery of exocrine pancreatic function in a teenager with cystic fibrosis treated with ivacaftor	12
Effectiveness of hypertonic saline nebulization in airway clearance in children with non‐cystic fibrosis bronchiectasis: A randomized control trial	12
Extracellular vesicles influence the pulmonary arterial extracellular matrix in congenital diaphragmatic hernia	12
Effectiveness of fractional exhaled nitric oxide for asthma management in children: A systematic review and meta‐analysis	12
Delayed season's onset and reduction of incidence of bronchiolitis during COVID‐19 pandemic	12
Risk factors for nontuberculous mycobacterial isolation in patients with cystic fibrosis: A meta‐analysis	12
Detection of bacterial pathogens using home oropharyngeal swab collection in children with cystic fibrosis	12
The return of RSV during the COVID‐19 pandemic	12
Thoracoscopy versus thoracotomy for congenital lung malformations treatment: A single center experience	12
Patients with cystic fibrosis and advanced lung disease benefit from lumacaftor/ivacaftor treatment	12
Clinical features and accompanying findings of Pseudo‐Bartter Syndrome in cystic fibrosis	12
Impact of pharmacy technicians as part of an integrated health‐system pharmacy team on improvement of medication access in the care of cystic fibrosis patients	12

A survey: Understanding the health and perspectives of people with CF not benefiting from CFTR modulators	12
Accuracy of lung and diaphragm ultrasound in predicting successful extubation in extremely preterm infants: A prospective observational study	12
Risk factors for redetectable positivity in recovered COVID‐19 children	12
Central airway issues in bronchopulmonary dysplasia	12
Co‐morbid anxiety and depression in childhood asthma and its effect on symptom control: A cross sectional study	12
Parent perspectives on facilitating decision‐making around pediatric home ventilation	12
Cytokine profile in Egyptian children and adolescents with COVID‐19 pneumonia: A multicenter study	12
Associations of Helicobacter pylori seropositivity and gastric inflammation with pediatric asthma	12
Chronic wet cough in Australian children: Societal costs and quality of life	12
Reference values for respiratory sinusoidal oscillometry in children aged 3 to 17 years	12
Factors associated with complicated pneumonia in children	12
Cardiorespiratory effects of NIV‐NAVA, NIPPV, and NCPAP shortly after extubation in extremely preterm infants: A randomized crossover trial	12
Greater length of stay and hospital charges for severe asthma in children with depression or anxiety	12
Understanding the environmental factors related to the decrease in Pediatric Emergency Department referrals for acute asthma during the SARS‐CoV‐2 pandemic	12
Overview of the ChILD Research Network: A roadmap for progress and success in defining rare diseases	12
Respiratory syncytial virus and SARS‐CoV‐2 coinfections in children	12
Patient and family perspectives regarding the use of telehealth for cystic fibrosis care	12
Sildenafil for pulmonary hypertension in neonates: An updated systematic review and meta‐analysis	12
Beyond transplant: Roles of atrial septostomy and Potts shunt in pediatric pulmonary hypertension	11
Incidence of nephrotoxicity with prolonged aminoglycoside exposure in patients with cystic fibrosis	11
Impact of elexacaftor/tezacaftor/ivacaftor on vitamin D absorption in cystic fibrosis patients	11
Epidemiologic Study of Cystic Fibrosis: 25 years of observational research	11
Clinical, functional, and computed tomography findings in a cohort of patients with neuroendocrine cell hyperplasia of infancy	11
The cost‐utility of intravenous magnesium sulfate for treating asthma exacerbations in children	11
Molecular characterization of Streptococcus pneumoniae isolated from pediatric patients in Shanghai, China	11
A proposal for the addressing the needs of the pediatric pulmonary work force	11
Outcomes of infants with severe bronchopulmonary dysplasia who received tracheostomy and home ventilation	11
COVID‐19: Impact, experiences, and support needs of children and young adults with cystic fibrosis and parents	11
Maternal iron status during early pregnancy and school‐age, lung function, asthma, and allergy: The Generation R Study	11
Lung function and exercise capacity in prematurely born young people	11
Early volume targeted ventilation in preterm infants born at 22–25 weeks of gestational age	11
Risk factors for respiratory syncytial virus bronchiolitis hospitalizations in children with chronic diseases	11
Ground glass and fibrotic change in children with surfactant protein C dysfunction mutations	11
Pulmonary manifestations of immune dysregulation in CTLA‐4 haploinsufficiency and LRBA deficiency	11
Sleep disordered breathing: Assessment and therapy in the age of emerging neuromuscular therapies	11
Incidence, predictors of success and outcome of LISA in very preterm infants	11
Cardiopulmonary phenotypic variability and discordance in Duchenne muscular dystrophy: Implications for new therapies	11
Diagnosis, management, and outcomes of pediatric tracheostomy‐associated infections: A scoping review	11
Evaluation of the novel coronavirus disease in Turkish children: Preliminary outcomes	11
Management of neuropsychiatric symptoms in adults treated with elexacaftor/tezacaftor/ivacaftor	11
Persistent tachypnea of infancy: Follow up at school age	11
A child with SARS‐CoV2‐induced croup	11
A systematic review of the clinical and genetic characteristics of Chinese patients with cystic fibrosis	11
Variation in cystic fibrosis newborn screening algorithms in the United States	10
Clinical change 2 years from start of elexacaftor‐tezacaftor‐ivacaftor in severe cystic fibrosis	10
Cerebral and splanchnic oxygenation during automated control of inspired oxygen (FiO2) in preterm infants	10
Oral antibiotic prescribing patterns for treatment of pulmonary exacerbations in two large pediatric CF centers	10
Phenotypic variance in pediatric obstructive sleep apnea	10
Lung ultrasound scores in neonatal clinical practice: A narrative review of the literature	10
Thoracic CTA in infants and young children: Image quality of dual‐source CT (DSCT) with high‐pitch spiral scan mode (turbo flash spiral mode) with or without general anesthesia with free‐breathing tec	10
Risk factors for recurrent pulmonary exacerbation in idiopathic pulmonary hemosiderosis	10
COVID‐19 in a child with tuberculous airway compression	10
The impact of elexacaftor/tezacaftor/ivacaftor on body composition in a small cohort of youth with cystic fibrosis	10
Newer bronchopulmonary dysplasia definitions and prediction of health economics impacts in very preterm infants	10
Risk factors for postoperative pulmonary complications in children with severely compromised pulmonary function secondary to severe scoliosis	10
Use of saliva sample to detect C‐reactive protein in children with pneumonia	10
How many billions is enough? Prioritizing profits over patients with cystic fibrosis	10
Metered‐dose inhalers versus nebulization for the delivery of albuterol for acute exacerbations of wheezing or asthma in children: A systematic review with meta‐analysis	10
The effect of telerehabilitation on quality of life, anxiety, and depression in children with cystic fibrosis and caregivers: A single‐blind randomized trial	10
Exercise testing for children with cystic fibrosis: A systematic review	10
Retrospective analysis of inpatient polysomnogram characteristics and discharge outcomes in infants with bronchopulmonary dysplasia requiring home oxygen therapy	10
Lung ultrasound scoring in invasive mechanically ventilated children with severe bronchiolitis	10
Intra‐tracheal surfactant/budesonide versus surfactant alone: Comparison of two consecutive cohorts of extremely preterm infants	10
Tracing the path of inhaled nitric oxide: Biological consequences of protein nitrosylation	10
“You're on mute!” Does pediatric CF home spirometry require physiologist supervision?	10
“New Trach Mom Here…”: A qualitative study of internet‐based resources by caregivers of children with tracheostomy	10
Pseudo‐Bartter syndrome in Chinese children with cystic fibrosis: Clinical features and genotypic findings	10
The ISPAT project: Implementation of a standardized training program for caregivers of children with tracheostomy	10
Prenatal exposure to VOCs and NOx and lung function in preschoolers	10
The association of vitamin D and vitamin E levels at birth with bronchopulmonary dysplasia in preterm infants	10
Vascular and pulmonary comorbidities in children with congenital EA/TEF	10
Ultrasound of pneumothorax in neonates: Diagnostic value of the anterior transverse plane and of mirrored ribs	10
Fatal SARS‐CoV‐2 Omicron variant in a young infant: Autopsy findings	10
Transcutaneous monitoring of diaphragm activity as a measure of work of breathing in preterm infants	10
Understanding the expanding role of pharmacy services in outpatient cystic fibrosis care	10
Do pulmonary and extrapulmonary features differ among cystic fibrosis, primary ciliary dyskinesia, and healthy children?	10
Life course body mass index through childhood and young adulthood and risks of asthma and pulmonary function impairment	10
Respiratory syncytial virus seropositivity at birth is associated with adverse neonatal respiratory outcomes	10
Gradual increase in sweat chloride concentration is associated with a higher risk of CRMS/CFSPID to CF reclassification	10
The many faces and outcomes of pulmonary vein stenosis in early childhood	10
Pulmonary functions in children and adolescents with sickle cell disease	10
Autophagy‐related 5 gene mRNA expression and ATG5 rs510432 polymorphism in children with bronchial asthma	10
An algorithm combining procalcitonin and lung ultrasound improves the diagnosis of bacterial pneumonia in critically ill children: The PROLUSP study, a randomized clinical trial	10
Outcomes of repeat sweat testing in cystic fibrosis newborn screen positive infants	9
Tracheobronchitis in children with tracheostomy tubes: Overview of a challenging problem	9
Viruses and Mycoplasma pneumoniae are the main etiological agents of community‐acquired pneumonia in hospitalized pediatric patients in Spain	9
Assessment of pulmonary function by impulse oscillometry and spirometry in children with type 1 diabetes mellitus	9
Can overnight portable pulse oximetry be used to stratify obstructive sleep apnea risk in infants? A correlation analysis	9
Impulse oscillometry in preschool children with persistent asthma can predict spirometry at school age	9
Quantifying continuous nebulization via high flow nasal cannula and large volume nebulizer in a pediatric model	9
Visuomotor reaction time and dynamic balance in children with cystic fibrosis and non‐cystic fibrosis bronchiectasis: A case‐control study	9
Sleep disorders in children with asthma	9
Can SARS‐CoV‐2 cause life‐threatening bronchiolitis in infants?	9
Caffeine citrate maintenance doses effect on extubation and apnea postventilation in preterm infants	9
Refinement of newborn screening for cystic fibrosis with next generation sequencing	9